News & Events 2011
CTI Clinical Trial and Consulting Services Announces President and CEO, Timothy J. Schroeder, to Present at “The Practice of Transplant Administration” Workshop
September 26, 2011
Timothy J. Schroeder will present at “The Practice of Transplant Administration” Workshop, which takes place September 26-27, 2011 and is presented by The Transplant Management Group, LLC. Mr. Schroeder will present on the topic of the Economics of Clinical Trials and their Potential Contributions to the Transplant Program. Schroeder ...
Read MoreAction Pharma’s phase IIb clinical trial with AP214 to prevent kidney injury associated with major cardiac surgery demonstrates positive top-line results
September 26, 2011
Action Pharma A/S today announced positive top-line results for its phase IIb AP214 trial in patients undergoing major cardiac surgery. The study demonstrated that AP214 is safe, reduces kidney injury, and improves long-term (90 days) outcomes on a composite end point (death, dialyses and kidney function) in patients undergoing cardiac ...
Read MoreCTI Clinical Trial and Consulting Services Announces that John R. Edwards, MD has joined as Medical Director
September 16, 2011
CTI Clinical Trial and Consulting Services (CTI) announces the addition of John R. Edwards, MD as Medical Director. Dr. Edwards brings to CTI extensive clinical experience in hematology, oncology and stem cell therapy. Dr. Edwards comes to CTI from Lifeforce Cryobanks where he served as the President/COO/CMO of the ...
Read MoreCTI Clinical Trial and Consulting Services Announces Dr. William Irish to Present at Food and Drug Administration Public Workshop
September 8, 2011
William Irish, PhD will present at the Food and Drug Administration (FDA) as part of the public workshop on the Effects of Ischemia Reperfusion Injury (IRI) on Outcomes in Kidney Transplant, taking place September 8-9, 2011. Dr. Irish will present on the topic of Cold Machine Perfusion versus Static Cold ...
Read MoreAugust Newsletter - The United States Renal Data System for Outcomes Research
August 1, 2011
Read MoreCTI Clinical Trial and Consulting Services Announces Dr. William Irish Appointed to Editorial Board of the American Journal of Transplantation
June 10, 2011
William Irish, PhD, has been appointed to the editorial board as Statistical Editor of the American Journal of Transplantation. Dr. Irish, Vice President of Health Outcomes and Biostatistics at CTI Clinical Trial and Consulting Services (CTI), is an internationally recognized expert in the areas of study design and analysis. He ...
Read MoreCTI Clinical Trial and Consulting Services Announces the Formation of CTI Clinical Trial and Consulting Services Spain SL
April 29, 2011
CTI Clinical Trial and Consulting Services (CTI) announces the formation of CTI Clinical Trial and Consulting Services Spain, SL. This new geographic office location will allow CTI to better meet the needs of its sponsors throughout Europe. Spain has always been a key contributor to the clinical research field and, ...
Read More
CTI Clinical Trial & Consulting Global Headquarters
Covington, KY 41011
Main Fax: +1.513.598.3426
Where Life-changing Therapies Turn First®
CTI is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization.
© 2017 CTI Clinical Trial and Consulting Services
All rights reserved.
Follow Us
